GSK gets USFDA nod for HIV-1 drug branded as Dovato Farhat Nasim9 April 2019 9:20 AM ISTGSK already has two-drug regimen Juluca on the market, but only for the smaller market of HIV patients that have received prior treatment. Dovato is...
Laurus Labs gets tentative USFDA approval for HIV combo drug Farhat Nasim4 Feb 2019 9:30 AM ISTHyderabad: Indian pharmaceutical player, Laurus Labs said Sunday it has received tentative approval from the United States Food and Drug...
NPPA fixes retail price of 68 drug formulations, check out details Medical Dialogues Bureau3 Nov 2018 11:14 AM ISTSome of the formulations whose price has been fixed by NPPA include Clarithromycin for Oral Suspension (CIPLA), Baclofen Oral Solution ( Sun Pharma),...
Cipla gets WHO approval to sell TB preventing drug in HIV patients Ruby Khatun Khatun1 Dec 2017 2:40 PM ISTNew Delhi: Drug major Cipla said it has received approval from the World Health Organisation (WHO) for Q-TIB, a combination drug indicated to help...
FDA approves first two-drug HIV regimen from GSK Ruby Khatun Khatun24 Nov 2017 10:37 AM ISTNEW YORK: The U.S. Food and Drug Administration (FDA) on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed...
New ARV drugs, early diagnosis key to beating AIDS epidemic: UNAIDS Ruby Khatun Khatun22 Nov 2017 10:15 AM ISTCAPE TOWN: Developing new antiretroviral (ARV) drugs and using technology for early diagnosis are among steps needed to sustain momentum in fighting...
GSK appoints scientist Barron as new Research and Development head Ruby Khatun Khatun10 Nov 2017 9:47 AM ISTLONDON: GlaxoSmithKline (GSK) has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head as new Chief...
CDSCO releases Risk classification of Medical Devices and IVDs savita thakur thakur8 Nov 2017 3:24 PM ISTThrough a recent notification, Drugs Controller General (India), Directorate General of Health Services, India's central medical device regulator, the...
Co-Diagnostics to sign purchase agreement with MEDCIS Pathlabs Ruby Khatun Khatun9 Sept 2017 9:34 AM ISTSANDY, Utah: Co-Diagnostics, Inc. ("Co-Diagnostics" or the "Company"), a molecular diagnostics company with a unique, proprietary platform for the...
GSK bets on pioneering cancer therapy with Adaptimmune deal Ruby Khatun Khatun9 Sept 2017 9:32 AM ISTLONDON: GlaxoSmithKline (GSK) said it has licensed the rights to Adaptimmune's pioneering T-cell therapy program to boost its pipeline in oncology,...
Mylan Launches Avonza in India for HIV Ruby Khatun Khatun10 Aug 2017 10:00 AM ISTHERTFORDSHIRE, England and PITTSBURGH: Mylan Pharmaceuticals Private Limited, a subsidiary of Mylan N.V., a leading global pharmaceutical company, has...
Zydus Cadila gets USFDA nod to market HIV drug Ruby Khatun Khatun10 Aug 2017 9:30 AM ISTNew Delhi: Drug firm Zydus Cadila on Tuesday said it has received the tentative approval from the US health regulator to market Abacavir and...
